drugset / Trial / NCT00724321

Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction at Altitude

NCT00724321

Phase 1 Withdrawn Loma Linda University
NaSingle-groupTriple-blindBasic science

Summary

The objective of this study is to determine if single dose administration of inhaled iloprost will reduce pulmonary artery pressure, reduce hypoxic pulmonary vasoconstriction and improve arterial oxygenation at rest and during exercise at high altitude.

Timeline

Start
2008-07
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified Inhaled

Indications

No indication recorded.